Page 733 - Read Online
P. 733

Palmieri et al. J Cancer Metastasis Treat 2020;6:55  I  http://dx.doi.org/10.20517/2394-4722.2020.105                    Page 7 of 8

               in tumor progression, showing further reduction of the number of clones, or a new increase of “random”
               mutations.


               In conclusion, additional study in larger series is required for further confirmation of these preliminary
               data and suggestions. A greater use of liquid biopsy is recommended for proper detection of genetic
               mutations and for “the right treatment in the right patient at the right time”.


               DECLARATIONS
               Acknowledgments
               Authors thank the support from the Regione Toscana - Istituto Toscano Tumori (ITT) (Project
               “Identification of genetic bases of individual predisposition to lung cancer in non-smokers”) and the ASSO
               (Associazione per lo Sviluppo della Scienza Oncologica) Onlus. This work was, in part, supported by the
               MIUR project “Dipartimenti di Eccellenza 2018-2022” to the Department of Medical Biotechnologies,
               University of Siena”. This work is generated within the ERN-EURACAN (European network for Rare Adult
               Aolid Cancer).

               Authors’ contributions
               Performed the experiments, analyzed the data and wrote the paper: Palmieri M
               Performed the experiments: Iuso N
               Wrote the paper: Cetta F
               Analyzed the data: Fallerini C, Tita R
               Took care of the clinical part of the study: Fava F, Fabbiani A
               Performed genetic counseling and provided patient samples: Baldassarri M, Mencarelli MA
               Designed the research strategy, analyzed the data, and wrote the paper: Renieri A, Frullanti E.

               Availability of data and materials
               The data that support the findings of this study are available from the corresponding author upon
               reasonable request.

               Financial support and sponsorship
               None.

               Conflicts of interest
               All authors declared that there are no conflicts of interest.

               Ethical approval and consent to participate
               The consent to participate was obtained from patients included in the study.

               Consent for publication
               The consent for publication was obtained from patients included in the study.

               Copyright
               © The Author(s) 2020.


               REFERENCES
               1.   Weinstein IB, Joe A. Oncogene addiction. Cancer Res 2008;68:3077-80.
               2.   Mader S, Pantel K. Liquid biopsy: current status and future perspectives. Oncol Res Treat 2017;40:404-8.
               3.   Merlo LM, Pepper JW, Reid BJ, Maley CC. Cancer as an evolutionary and ecological process. Nat Rev Cancer 2006;6:924-35.
               4.   Greaves M, Maley CC. Clonal evolution in cancer. Nature 2012;481:306-13.
   728   729   730   731   732   733   734   735   736   737   738